BENGALURU, India and CHICAGO, Dec. 2, 2025 /PRNewswire/ -- Tata Elxsi, a global leader in design and technology services, has ...
Accord Healthcare today announced the launch of Osvyrti (denosumab), a biosimilar to Prolia® (Amgen), and Jubereq (denosumab) ...
Frost & Sullivan is pleased to announce that ZAGENO has been recognized with the 2025 Global Company of the Year Recognition in the ...
Power Construction Corporation of China ("POWERCHINA" or "the Company"), with multiple infrastructure projects across six continents, ...